World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
121
Citations
59818
World Ranking
3583
National Ranking
1976

Joseph R. Calabrese publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Joseph R. Calabrese sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 595 publications — 71st percentile

71% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Joseph R. Calabrese D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Joseph R. Calabrese sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 121 D-Index — 83rd percentile

83% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Joseph R. Calabrese is affiliated with Case Western Reserve University in the United States. Their research primarily focuses on Medicine, with a significant emphasis on Psychiatry and Mental Health, Pharmacology, Biological Psychiatry, Clinical Psychology, and Genetics.

The scientist's work covers several main topics including Bipolar Disorder and Treatment, Treatment of Major Depression, Schizophrenia research and treatment, Tryptophan and brain disorders, Electroconvulsive Therapy Studies, Adolescent and Pediatric Healthcare, and Stress Responses and Cortisol.

Frequent co-authors collaborating with Joseph R. Calabrese include Keming Gao, Caroline M. Nievergelt, Adam X. Maihofer, Melvin G. McInnis, and John I. Nürnberger.

Common publication venues for their work are Psychopharmacology Bulletin, Journal of Affective Disorders, Neuropsychopharmacology, Bipolar Disorders, and bioRxiv (Cold Spring Harbor Laboratory).

Notable recent papers authored or co-authored by Joseph R. Calabrese consist of:

  • Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial, 2021, American Journal of Psychiatry
  • A randomized proof-of-mechanism trial applying the 'fast-fail' approach to evaluating κ-opioid antagonism as a treatment for anhedonia, 2020, Nature Medicine
  • Genome-wide association analyses identify 95 risk loci and provide insights into the neurobiology of post-traumatic stress disorder, 2024, Nature Genetics
  • Selective kappa-opioid antagonism ameliorates anhedonic behavior: evidence from the Fast-fail Trial in Mood and Anxiety Spectrum Disorders (FAST-MAS), 2020, Neuropsychopharmacology
  • Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) recommendations for the management of patients with bipolar disorder with mixed presentations, 2021, Bipolar Disorders

Best Publications

  • Development and validation of a screening instrument for bipolar spectrum disorder: the Mood Disorder Questionnaire.

    Robert M.A. Hirschfeld;Janet B.W. Williams;Robert L. Spitzer;Joseph R. Calabrese

  • Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder

    Lakshmi N Yatham;Sidney H Kennedy;Sagar V Parikh;Ayal Schaffer

  • A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression

    Joseph R. Calabrese;Charles L. Bowden;Gary S. Sachs;John A. Ascher

  • Efficacy of Divalproex vs Lithium and Placebo in the Treatment of Mania

    Charles L. Bowden;Andrew M. Brugger;Alan C. Swann;Joseph R. Calabrese

  • Efficacy of Olanzapine and Olanzapine-Fluoxetine Combination in the Treatment of Bipolar I Depression

    Mauricio Tohen;Mauricio Tohen;Eduard Vieta;Joseph R Calabrese;Terence A. Ketter

  • Effectiveness of Adjunctive Antidepressant Treatment for Bipolar Depression

    Gary S. Sachs;Andrew A. Nierenberg;Joseph R. Calabrese;Lauren B. Marangell

  • A Randomized, Double-Blind, Placebo-Controlled Trial of Quetiapine in the Treatment of Bipolar I or II Depression

    Joseph R. Calabrese;Paul E. Keck;Wayne Macfadden;Margaret Minkwitz

  • A Randomized, Placebo-Controlled 12-Month Trial of Divalproex and Lithium in Treatment of Outpatients With Bipolar I Disorder

    Charles L. Bowden;Joseph R. Calabrese;Susan L. McElroy;Laszlo Gyulai

  • A Placebo-Controlled 18-Month Trial of Lamotrigine and Lithium Maintenance Treatment in Recently Manic or Hypomanic Patients With Bipolar I Disorder

    Charles L. Bowden;Joseph R. Calabrese;Gary Sachs;Lakshmi N. Yatham

  • A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder

    Joseph R. Calabrese;Charles L. Bowden;Gary Sachs;Lakshmi N. Yatham

  • Screening for bipolar disorder in the community

    Robert M.A. Hirschfeld;Joseph R. Calabrese;Myrna M. Weissman;Michael Reed

  • The International Society for bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders

    Isabella Pacchiarotti;David J. Bond;Ross J. Baldessarini;Willem A. Nolen

  • Efficacy of quetiapine monotherapy in bipolar I and II depression: a double-blind, placebo-controlled study (the BOLDER II study).

    Michael E. Thase;Wayne Macfadden;Richard H. Weisler;William Chang

  • A double-blind, placebo-controlled, prophylaxis study of lamotrigine in rapid-cycling bipolar disorder

    Joseph R. Calabrese;Trisha Suppes;Charles L. Bowden;Gary S. Sachs

  • Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program

    David J. Miklowitz;Michael W. Otto;Ellen Frank;Noreen A. Reilly-Harrington

  • Rationale, design, and methods of the systematic treatment enhancement program for bipolar disorder (STEP-BD)

    Gary S Sachs;Michael E Thase;Michael W Otto;Mark Bauer

  • Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009.

    Lakshmi N Yatham;Sidney H Kennedy;Ayal Schaffer;Sagar V Parikh

  • Efficacy of olanzapine in combination with valproate or lithium in the treatment of mania in patients partially nonresponsive to valproate or lithium monotherapy.

    Mauricio Tohen;Mauricio Tohen;K. N. Roy Chengappa;Trisha Suppes;Carlos A. Zarate

  • The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders

    Mauricio Tohen;Mauricio Tohen;Ellen Frank;Charles L. Bowden;Francesc Colom

  • Depression During Mania: Treatment Response to Lithium or Divalproex

    Alan C. Swann;Charles L. Bowden;David Morris;Joseph R. Calabrese

Frequent Co-Authors

Charles L. Bowden
Charles L. Bowden The University of Texas Health Science Center at San Antonio
Robert L. Findling
Robert L. Findling Virginia Commonwealth University
Gary S. Sachs
Gary S. Sachs Harvard University
Michael E. Thase
Michael E. Thase University of Pennsylvania
Terence A. Ketter
Terence A. Ketter Stanford University
Sandro Galea
Sandro Galea Washington University in St. Louis
Andrew A. Nierenberg
Andrew A. Nierenberg Harvard University
Israel Liberzon
Israel Liberzon Texas A&M University
Eric A. Youngstrom
Eric A. Youngstrom University of North Carolina at Chapel Hill
Mauricio Tohen
Mauricio Tohen University of New Mexico

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you consider studying Medicine in the USA, it’s important to know about alternative and complementary education and career options within healthcare. Many students begin their professional journey with a 6 month lpn program. These fast-track pathways can offer a quick entry to the healthcare field, allowing you to gain hands-on experience while still pursuing further studies.

If you are interested in mental health care, psych np online programs provide a flexible route to advanced nursing roles that focus on psychiatric and mental health services. These online degrees are ideal for working professionals who want to specialize without pausing their careers.

For those interested in the management side of healthcare, there are excellent options like online healthcare administration programs. These degrees can prepare you for leadership positions in hospitals, clinics, and beyond.

If you wish to advance further, a master's in healthcare administration online will develop your management and policy skills for careers in healthcare leadership. Exploring these related degrees can help you find the best fit for your goals and long-term career priorities.

Best Scientists Citing Joseph R. Calabrese

Trending Scientists

Recently Published Articles